In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Integra Lifesciences Holdings Corp. (NASDAQ:IART) reported that Caruso Richard E. has picked up 6,201,027 of common stock as of 2017-02-13.

The acquisition brings the aggregate amount owned by Caruso Richard E. to a total of 6,201,027 representing a 16.57% stake in the company.

For those not familiar with the company, Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.

A glance at Integra Lifesciences Holdings Corp (NASDAQ:IART)’s key stats reveals a current market capitalization of 3.20 billion based on 74.77 million shares outstanding and a price at last close of $42.90 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2011-11-02, Caruso picked up 2,000 at a purchase price of $28.46. This brings their total holding to 2,000 as of the date of the filing.

On the sell side, the most recent transaction saw Arduini unload 20,000 shares at a sale price of $80.02. This brings their total holding to 25,593.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Integra Lifesciences Holdings Corp. (NASDAQ:IART) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.